It has been proposed that the synergy of ATRA and ATO reverses the characteristic disorganization of promyelocytic leukemia (PML) bodies, as also observed in all types of NPM1-mutated AML, apart from APL. The gene discussed is NPM1; the disease is acute myeloid leukemia.